NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance. Geneva: World Health Organization; 2013.

Cover of The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis

The Use of Bedaquiline in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance.

Show details

Annex 2Expert Group members


  • Dr Holger Schünemann
    Chair, Department of Clinical Epidemiology & Biostatistics
    McMaster University
    1280 Main St W., HSC 2C16
    L8S 4K1 – Hamilton, ON


  • Dr Elie Akl
    Associate Professor of Medicine and Director,
    Unit of Clinical Epidemiology
    Department of Internal Medicine
    American University of Beirut Medical Center P.O. Box: 11-0236
    Beirut 1107 2020
  • Dr Adekunle Victor Babawale
    National TB, Leprosy & Buruli Ulcer Control Programme,
    Akwa Ibom House
    Plot 540, Constitution Avenue
    Central Bussiness District, 900211
    Federal Capital Territory-Abuja
  • Dr Mauricio L. Barreto
    Professor in Public Health Epidemiology
    Instituto de Saude Coletiva
    Universidade Federal da Bahia
    Rua Basílio da Gama s/n – Canela
    40110-040 Salvador
  • Dr Martien W. Borgdorff
    Professor of Epidemiology
    Public Health Service Amsterdam
    Department of Infectious Diseases
    Nieuwe Achtergracht 100
    1018 WT Amsterdam
    The Netherlands
  • Dr Erlina Burhan
    Department of Pulmonology and Respiratory Medicine
    Faculty of Medicine, University of Indonesia
    Persahabatan Hospital
    Jl. Persahabatan Raya No.1, Rawamangun
    Jakarta 13230
  • Dr Richard E. Chaisson
    Professor of Medicine, Epidemiology and International Health
    Center for Tuberculosis Research
    Johns Hopkins University
    1503 E. Jefferson Street
    21231-1003 – Baltimore, Maryland
  • Ms Lucy Chesire
    Executive Director
    TB Advocacy
    Ambassador Court, Block A5
    P.O. BOX 50358 – 00100
  • Ms Erica Lessem
    Assistant Director, TB/HIV Project
    Treatment Action Group
    261 Fifth Avenue, Suite 2110
    New York, NY 10016
  • Dr Norbert Ndjeka
    Drug-Resistant TB, TB & HIV
    National TB Control & Management Cluster
    Office N709, North Tower Civitas Building
    Corner Andries & Struben Streets
    South Africa
  • Dr Viet Nhung Nguyen
    Vice Director of National Lung Hospital
    Standing Deputy Manager of Vietnam NTP
    Standing Vice Chair, Stop TB Partnership
    Vice President, VATLD
    GLC member WHO / WPRO
    463 Hoang Hoa Tham, Ba Dinh
    Viet Nam
  • Dr Michael L. Rich
    Partners in Health
    Harvard Medical School
    641 Huntington Avenue
  • Dr Simon Schaaf
    Department of Paediatrics and Child Health
    Faculty of Medicine and Health Sciences
    Cape Town
    South Africa
  • Dr Susan van den Hof
    Senior epidemiologist
    KNCV Tuberculosis Foundation
    PO Box 146, 2501 CC The Hague
    Parkstraat 17, 2514 JD The Hague
    The Netherlands
  • Dr Francis Varaine
    Médecins sans Frontières – France
    8 rue St Sabin 75444
    Paris Cedex 11
  • Dr Andrew A. Vernon
    Clinical and Health Systems Research
    Centers for Disease Control and Prevention
    MS E-10
    1600 Clifton Rd NE
    30333 – Atlanta, GA
  • Dr Piret Viiklepp
    Head of Estonian Tuberculosis Registry
    Co-coordinator of National TB Program
    National Institute for Health
    Development Hiiu 42 Tallinn, 11619


  • Dr Xiumin Huo
    Chief Pharmacist
    Office of Pharmacy Evaluation I
    Center for Drug Evaluation
    State Food and Drug Administration
  • Dr Ya Diul Mukadi
    Global Health Bureau
    United States Agency for International Development (USAID)
    1300 Pennsylvania Ave NW
    Office 5.7–40
    Washington D.C. 20523

Technical Resource Consultants

  • Dr Bernard Fourie
    Extraordinary Professor
    Medical Microbiology
    University of Pretoria
    PO Box 749, La Montagne
    South Africa, 0184
  • Dr Ekaterina Kurbatovaparticipated through video conference
    Senior Service Fellow
    MDR-Team, International Research and Programs Branch
    Division of TB Elimination/NCHHSTP
    U.S. Centers for Disease Control and Prevention (CDC)
    Mailstop E-10
    1600 Clifton Road, NE
    Atlanta, Georgia, 30333
  • Dr Charles Peloquin – participated through video conference
    Infectious Disease Pharmacokinetics Laboratory
    College of Pharmacy, and Emerging Pathogens Institute
    University of Florida
    1600 SW Archer Rd., Rm P4–33
    Gainesville, FL 32610–0486
  • Dr Anna Vassall –participated through video conference
    London School of Hygiene and Tropical Medicine
    Keppel Street
    London WC1E 7HT
    United Kingdom


  • STB Secretariat
    Dennis Falzon
    Haileyesus Getahun
    Malgosia Grzemska
    Ernesto Jaramillo
    Christian Lienhardt
    Mario Raviglione
    Fraser Wares
    Diana Weil
    Karin Weyer
    Joël Keravec, WHO/TBP/GDF
    Lisa Hedman, WHO/EMP
    Kris Weerasuriya, WHO/EMP
    Piero Olliaro, WHO/TDR
    Brenda Waning, UNITAID
  • GRC (observers)
    Charles Penn, WHO/AIP
    Susan Norris
Copyright © World Health Organization 2013.

All rights reserved. Publications of the World Health Organization are available on the WHO web site ( or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO web site (

Bookshelf ID: NBK154132


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...